BackgroundWhile ensuring vaccine access for migrants is a crucial public health goal in the UK and worldwide, migrants remain an under-immunised group. The provision of catch-up vaccination for adult migrants is often faced with institutional, infrastructural, and socio-cultural barriers. This research aims to explore experiences with catch-up vaccination among Russian-speaking migrants in the UK—a group that has been under-represented in research despite its increase since 2022. Methods25 semi-structured interviews were conducted with Russian-speaking migrants in July–August, 2022. A combination of purposive and snowball sampling was used to recruit the participants. All interviews were transcribed verbatim and analysed thematically using Atlas.ti software. Themes for analysis included participants’ experiences with the UK healthcare system, experiences with obtaining vaccination-related information, and practices with catch-up vaccines. FindingsThe majority of participants were from Russia (n=18) with others coming from Latvia (3), Ukraine (2), Belarus (1), and Kazakhstan (1); and most participants were asylum seekers (n=15). 13 participants were males and 12 were females. Seven asylum seekers identified as men who have sex with men (MSM). Apart from language and logistical barriers to access vaccination, participants highlighted lack of centralisation in vaccination provision and difficulty in accessing vaccination within the asylum centres as major challenges. All participants were aware of adult vaccines against COVID-19 and influenza, however, only MSM asylum seekers were familiar with and actively seeking vaccination against hepatitis A and B, HPV and mpox. Importantly, MSM participants highlighted that sexual health clinics are their first point of contact for receiving vaccine-related information and vaccination. InterpretationDespite important barriers to accessing vaccination in the UK, the research participants were proactive in seeking vaccination. Findings from this study indicate that other models of care need to be further explored and evaluated, beyond primary care, for delivering vaccines to diverse migrant groups. FundingAD is funded by the MRC (MR/N013638/1). SH is funded by the NIHR (NIHR300072), the Academy of Medical Sciences (SBF005I1), La Caixa Foundation (LCF/PR/SP21/52930003), Research England, MRC, and WHO. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care and UKHSA.
Read full abstract